In Vitro Effects of a Phosphodiesterase Inhibitor Sildenafil on Cellular Motility of the Oral Malignant Melanoma Cells

Shimizu Kasumi DDS, PhD, Department of Oral and Maxillofacial Surgery, Department of Clinical Sciences Medical life Science Mie University Graduate School of Medicine, Tsu, Japan
Taku Murata DDS, PhD, Department of Oral and Maxillofacial Surgery, Department of Clinical Sciences Medical life Science Mie University Graduate School of Medicine, Tsu, Japan
Hiroshi Morita DDS, PhD, Department of Oral and Maxillofacial Surgery, Department of Clinical Sciences Medical life Science Mie University Graduate School of Medicine, Tsu, Japan
Madoka Inui DDS, PhD, Department of Oral and Maxillofacial Surgery, Department of Clinical Sciences Medical life Science Mie University Graduate School of Medicine, Tsu, Japan
Naoya Arai DDS, PhD, Department of Oral and Maxillofacial Surgery, Department of Clinical Sciences Medical life Science Mie University Graduate School of Medicine, Tsu, Japan
The prognosis for malignant melanoma is poor; therefore, new diagnostic methods and treatment strategies are urgently needed. By catalyzing the hydrolysis of cyclic nucleotides (cAMP and/or cGMP), phosphodiesterases (PDEs) regulate the intracellular concentrations and effects of these secondary messengers. Eleven PDE gene families (PDE1-11) have been identified and the inhibitors of those PDEs are now clinically used for the treatment of non-malignant diseases like pulmonary hypertension, erectile dysfunction, etc.1)Until now, we have reported the PDE1 expressions and functions in various oral malignant tumors. We have also demonstrated that sildenafil, one of the PDE inhibitors, suppressed migration of the human oral melanoma MAA cells through the PDE1-cAMP pathway. Here, we examined the effect of sildenafil on viability and invasion of MAA cells. We also studied the effect of Ht31, a protein kinase A (PKA) -anchoring inhibitor, on the migration of MAA cells because PKA is involved in the PDE-cAMP pathway.

       Human oral malignant melanoma MAA cells were established and maintained in our laboratory.

Cell viability assay. MAA cells (5×104cells/well) were plated in 24 wells and cultured for 24 hours. Then, the cells were treated with sildenafil for 3 days (5 μM and 10 μM). Trypan Blue Stain at 0.4% was added to the cells and both living and dead cells were counted under a microscope.

In vitro invasion assays. MAA cells (1×104cells) in RPMI 1640 medium containing 0.1% FBS were transferred to 8 mm pore Matrigel pre-coated inserts with or without sildenafil. The inserts were placed in companion wells containing medium supplemented with 10% FBS as a chemoattractant. Following 5 hours incubation, the non-invading cells were removed from the upper surface of the membrane. The cells on the lower surface of the membrane were fixed, stained with Diff‑Quik, and counted under a microscope.

In vitro migration assay.The procedures were basically same as the above invasion assay except that simple 8-μm pore inserts were used instead of the Matrigel-coated inserts. The effects of Ht-31 on cell migration were assessed by the number of the cells on the lower surface of the membrane.

       The differences among multiple groups were analyzed using Tukey-Kramer multiple comparison test, and the difference between two groups were analyzed using Student's t-test.

       As the results, sildenafil at the concentrations used in this study did not show any significant effects on cell viability and invasion of the MAA cells. On the other hand, Ht31 inhibited migration of the MAA cells.

       The present results showed that sildenafil could not inhibit the invasion of MAA cells, although our previous study had demonstrated that sildenafil suppresses migration of these cells. Ht-31, a PKA inhibitor, inhibited cell migration in this study. As it is known that PKA exists downstream the PDE-cAMP signaling, it is suggested that sildenafil can affect PDE signaling and cell motility, but not cell invasion which needs degradation of matrix. Due et al.2), have reported that PKA is a key regulator of Rho families. So, further studies on PDE, PKA and Rho family are necessary to expect the possibility of sildenafil for inhibiting metastasis of melanoma cells.

1. Joseph, B.A., Sharron, F.H., et al.: Cyclic Nucleotide Phosphodiesterases in Health and Disease. First Edition pp.1-17, CRC Press Taylor & Francis Group, the United States of America, 2006.

2. Dua P, Gude RP. Pentoxifylline impedes migration in B16F10 melanoma by modulating Rho GTPase activity and actin organisation. Eur J Cancer 44(11):1587-95, 2008